For those who will attend the AGM in Taipeng, appreacite if can help to ask the following questions:
[a] FDA [b] What is their current capacity 4.3bil?? [c] What will be their additional new capacity in FY19? [d] Also their capacity roadmap for the next 5 yrs. [e] % revenue of their export to China.
They never share much capacity information to avoid been closely monitor by their competitors. (this is smart move). Top Glove capacity is 50bil and its 10% of cap already can make CG koyak.
Note: Capacity and China market will be key growth for any glove company.
@VFTRADER I'll help you to ask your questions (a) - (e). Good and pertinent questions.
I'm a Taiping resident and I'm attending the AGM. My house is about 5 minutes from the venue, Legend Inn Hotel.
Have some interest in Comfort stock recently. I purposely bought some token shares to get the right to attend the AGM. I want to understand the company firsthand.
Will increase my position pending my experience, observations and outcome of the AGM. Have read through the Annual Report.
BREAKING news. Comfort is buying a piece of vacant industrial land at 13.2 million for future expansion. Payment is to be done through internally-generated funds.
Bursa Announcement: "On behalf of the Board of Directors of CGB, we wish to announce that CRGI, a wholly-owned subsidiary of CGB had on 22 June 2018 entered into a Sale and Purchase Agreement to acquire a piece of leasehold vacant land held under PN271977, Lot No. 312712, Mukim Sungai Terap, Daerah Kinta, Perak measuring approximately 157,500 sq. meters from NMSB for a total cash consideration of RM13,223,465.00."
[Currrent] a)Total 3 factories at 3 different plot total 17acres w 4.3bil cap (not sure fully occupied?). b) Vacant land=9.75 acres. c) New buy = 39acres.
[Future] so b+c easily can hv additional cap of 13.0bil.
Sweat dream by 5 yrs later: QR rev can hit RM500mil w 10% NP at RM50mil.
Base on report.. doesn't see any effect from FDA.. business doing fine, just currency n raw material cost higher.. worry clear. Should back to rm1 at least
Lucky the FDA no affect sales. Currency and cost of materials rise only which every company can't really control. Revenue increase shows good demand. Okay, will start buy tomorrow.
Bad result . Profit drop about 30% compare to last year quarter. Inventory increase 10 million. Sure many gloves return due to fda. Better sell tomorrow to avoid more bad news coming.
If fda cause major impact.. I don't think can get this revenue... Mean they able to deliver another batch product to USA.. those inventories that return by fda able to deliver after qc again..
What so worry since fda no affect their business at USA ? = (
Quarter result does not affect earnings. Revenue already tells you the answer. Next quarter result should be good since inventory increase tandem against revenue.
3.6 Inventories Inventories are measured at the lower of cost and net realisable value. Cost is determined using the first-in first-out basis for manufacturing and trading inventories. The costs comprise the purchase price plus costs incurred to bring the inventories to their present locations and conditions. The cost of manufactured finished goods and work-in-progress consist of raw materials, direct labour and a proportion of manufacturing overheads based on normal operating capacity. Net realisable value is the estimated selling price in the ordinary course of business, less the estimated costs of completion and selling expenses.
New IPO: Building management systems (BMS), solar thermal systems and energy-saving services provider, Solar District Cooling Bhd aims to list on the Ace Market!
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
smartinvestor2
40 posts
Posted by smartinvestor2 > 2018-06-20 18:30 | Report Abuse
come out or no come out no difference.
Sure big red.